i.coelho
TL2 · Rijeka
Contributes reviews on supplier material. Based in Rijeka.
Joined 11 August 2025 · last posted 7d
86 posts, newest first. Showing up to 150.
-
Coming back to: Payment method and the leverage it gives you, ranked Replied, post #24 · Sourcing › Payments · 21 Jul 2026 · 7 likes Whatever method is used, the record of what was ordered and what was quoted is the thing that matters afterwards. Screenshots of a cart are not a record. Reading it…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #122 · Evidence › Journal club · 20 Jul 2026 · 32 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to. Adding the…
-
Coming back to: Batch date after test date, and other internal inconsistencies Replied, post #6 · Analytics › COA interpretation · 7 Jul 2026 · 5 likes Batch date is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty minutes…
-
An 18-month record including the parts that went badly Replied, post #54 · Outcomes › Progress reports · 29 Jun 2026 · 18 likes I read post #50 twice before replying, because I had assumed the opposite. Medication changes: escalating dose, or adding or removing other medications, can affect the…
-
When your prescriber and the evidence disagree Replied, post #16 · Clinical › Prescriber conversations · 26 Jun 2026 · 6 likes Post #14 answers the question as asked. The question underneath it is different. Prescription logistics: confirm whether it will be filled locally, requires mail order,…
-
Tracking intake honestly when appetite is absent Replied, post #73 · Nutrition & Training › Protein & intake · 25 Jun 2026 · 0 likes Helpful, and short, which on this subject is harder than long.
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #35 · Access › International · 25 Jun 2026 · 0 likes Following this. I have the same question and no better information than the first post.
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #12 · Practice › Side effects · 24 Jun 2026 · 17 likes Practical answer on Muscle cramps, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #31 · Pharmacology › Pharmacokinetics · 22 Jun 2026 · 3 likes The accumulation ratio for weekly dosing with a week-long half-life is around two, which is why the concentration after several doses is roughly double the…
-
Documenting a supplier's response to a discrepancy Replied, post #20 · Sourcing › Vendor reports · 21 Jun 2026 · 20 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #4 · Practice › Side effects · 18 Jun 2026 · 2 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
-
Revisiting: The best-written scientific paper you have read Replied, post #38 · Lounge › Off topic · 18 Jun 2026 · 0 likes Adjacent and interesting: you might post something about nutrition, bioavailability from a food perspective, or the sociology of weight. Adjacent to this community's…
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #55 · Clinical › Comorbidities · 13 Jun 2026 · 2 likes The arithmetic in post #53 is right; the assumption feeding it is the part to check. The confident answers on gastro-oesophageal reflux and the well-sourced answers are…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #60 · Compounds › Semaglutide · 12 Jun 2026 · 0 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
Reused chromatograms across lots: how to spot it Replied, post #47 · Analytics › COA interpretation · 6 Jun 2026 · 27 likes This follows post #46 rather than contradicting it. The version of reused chromatograms across lots that I was taught turned out to be a teaching simplification.…
-
Request: a per-category review queue Replied, post #12 · Meta › Feature requests · 31 May 2026 · 2 likes Modest request: remember my sort preference per category rather than globally. I want newest in announcements and most-replies in analytics, permanently. Filing this…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #57 · Devices › Syringes & needles · 31 May 2026 · 0 likes Source for the 0.3 ml versus 0.5 ml figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger…
-
Peak-to-trough ratio at steady state for a weekly agent Replied, post #3 · Pharmacology › Pharmacokinetics · 29 May 2026 · 3 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
-
Blind submission and why it changes minds — the long version Replied, post #83 · Sourcing › Independent verification · 18 May 2026 · 19 likes The reason Blind submission is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other is…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #17 · Analytics › Impurities & related substances · 13 May 2026 · 0 likes Worth separating two things that post #15 runs together. Two claims get bundled together under Endotoxin and they need separating. The descriptive one — this is what…
-
Five questions in one post gets you one answer — how to split them Replied, post #78 · Start Here › How to Ask · 11 May 2026 · 1 like Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
-
Blind submission and why it changes minds — the long version Replied, post #68 · Sourcing › Independent verification · 10 May 2026 · 2 likes Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want.
-
Bariatric surgery history: altered anatomy, altered expectations Replied, post #5 · Clinical › Special populations · 10 May 2026 · 1 like Building on post #4 rather than restating it. Genetic and ancestry-related differences in response are asked about regularly and the published evidence is thin enough…
-
Journal club: is percentage weight change the right endpoint? Replied, post #119 · Evidence › Journal club · 30 Apr 2026 · 5 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #107 · Practice › Reconstitution · 24 Apr 2026 · 10 likes Post #104 is right about the mechanism and I think understates the practical bit. Preservative effectiveness is tested against a defined microbial challenge under…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #45 · Clinical › Bloodwork · 21 Apr 2026 · 11 likes Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most people realize. Comparing your result to the reference…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #95 · Analytics › Mass spectrometry · 19 Apr 2026 · 0 likes Coming back to post #91, because the follow-up matters more than the original answer. Calibration state at the time of the run determines whether the ppm figure means…
-
[2026 update] Comparing prices across jurisdictions without misleading yourself Replied, post #2 · Access › Pricing · 13 Apr 2026 · 0 likes Everything in the opening post holds. The case it does not cover is the one I have. A price well below the rest of the market is a fact rather than a finding, and it is…
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #26 · Data & Tools › Calculators · 4 Apr 2026 · 0 likes Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat: "equivalence" is not precise and individual response varies.…
-
Coming back to: Time to steady state after a dose increase Replied, post #26 · Pharmacology › Pharmacokinetics · 4 Apr 2026 · 21 likes Understood, and I withdraw the assumption I opened with.
-
The "under review" status pill and when a moderator applies it Replied, post #20 · Evidence › Preprints · 14 Mar 2026 · 11 likes The arithmetic in post #17 is right; the assumption feeding it is the part to check. Reading a preprint properly means doing some of the reviewer's job: methods first,…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #60 · Analytics › Mass spectrometry · 7 Mar 2026 · 21 likes Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge states. Reading an electrospray spectrum means…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #85 · Evidence › Study critique · 25 Feb 2026 · 1 like Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either…
-
Follow-up: "Should I double up?" — answered once, at length, calmly Started this topic · Practice › Administration · 21 Feb 2026 · 22 likes On the subject in the title: "Should I double up?" — answered once, at length, calmly Working notes rather than a conclusion. A practical question that I suspect has a…
-
What a good consultation looks like from the other side Replied, post #18 · Clinical › Prescriber conversations · 20 Feb 2026 · 17 likes Filing a mild objection to the consensus on good consultation. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #12 · Start Here › Welcome · 12 Feb 2026 · 2 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
A plateau that disappeared when I changed how I measured — the long version Replied, post #7 · Outcomes › Progress reports · 10 Feb 2026 · 9 likes Self-reported intake is optimistic in a consistent direction, and saying so in your own report is more credible than not.
-
Revisiting: Absolute versus relative contraindications Replied, post #3 · Safety › Contraindications · 2 Jan 2026 · 0 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
-
The headache that turns out to be dehydration Replied, post #108 · Nutrition & Training › Hydration & electrolytes · 24 Dec 2025 · 26 likes Where I part company with post #106, and it is a narrow parting. Symptoms attributed to electrolytes here are non-specific and overlap with dehydration, low intake and…
-
How to read a phase 2 result without treating it as a phase 3 result Replied, post #30 · Compounds › Retatrutide · 21 Dec 2025 · 20 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
-
DXA precision and the least significant change for lean mass Replied, post #51 · Outcomes › Body composition · 8 Dec 2025 · 0 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Reading SURMOUNT-1 without the press release Replied, post #86 · Compounds › Tirzepatide · 2 Dec 2025 · 2 likes I read post #83 twice before replying, because I had assumed the opposite. Filing a mild objection to the consensus on reading SURMOUNT-1 without the press. Mild…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile… Replied, post #10 · Compounds › Semaglutide · 28 Nov 2025 · 0 likes On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent with semaglutide and is also consistent with several closely related species.…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #65 · Compounds › Other compounds · 25 Nov 2025 · 1 like Helpful, and short, which on this subject is harder than long.
-
Lurking for two months before posting: was that the right call? Replied, post #61 · Start Here › Welcome · 20 Nov 2025 · 0 likes Worth knowing early: the archive is not retrospectively corrected. A topic from two years ago was accurate when written and may not be now. Every post carries its date…
-
Availability by country, dated, with primary sources Replied, post #48 · Access › International · 6 Nov 2025 · 0 likes Nothing here is legal advice, and in this subcategory that caveat is doing real work rather than sitting decoratively at the end. This is the sort of thing that ought…
-
Long-time reader, first-time poster Replied, post #2 · Lounge › Introductions · 31 Oct 2025 · 0 likes Before the thread moves on from long-time reader — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #83 · Sourcing › Vendor reports · 31 Oct 2025 · 0 likes Post #82 is the version of this I will quote in future. One addition. Checked the vendor documentation pages claim against the primary source this morning. It survives,…
-
Sleep tracking data and its considerable limitations Replied, post #107 · Wellbeing › Sleep · 27 Oct 2025 · 9 likes Consumer sleep trackers measure movement and heart rate and infer stages. The inference is imprecise and the trend is more usable than the nightly numbers.
-
Second pass at: Programming during a large energy deficit Replied, post #53 · Nutrition & Training › Resistance training · 25 Oct 2025 · 0 likes Everything in post #51 holds. The case it does not cover is the one I have. Maintaining load with reduced volume is a reasonable strategy during a deficit and appears…
-
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #3 · Sourcing › Regulatory · 25 Oct 2025 · 0 likes The opening post is right about the mechanism and I think understates the practical bit. Pharmaceutical compounding rules looks different depending on whether you are…
-
Personal import allowances, compared — a second dataset Replied, post #8 · Access › International · 10 Oct 2025 · 5 likes What I would tell a new member reading about Personal import allowances for the first time: the confident posts are not the reliable ones, and the reliable ones are…
-
Compounds this community declines to help with, and why Replied, post #81 · Compounds › Other compounds · 8 Oct 2025 · 21 likes Noted, and thank you for writing it out rather than summarising it.
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #78 · Compounds › Cagrilintide & amylin analogues · 4 Oct 2025 · 5 likes The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere else: a mass consistent with the proposed structure is a necessary condition and…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #85 · Practice › Administration · 29 Sep 2025 · 11 likes Worth separating pinch as a question about the compound from pinch as a question about the documentation. They get answered by different people and only one of them is…
-
Research-use-only labelling: what it means and what it does not Replied, post #37 · Sourcing › Regulatory · 23 Sep 2025 · 2 likes On research-use-only labelling the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
Titles that describe the question, not the situation — what changed since Replied, post #22 · Start Here › How to Ask · 17 Sep 2025 · 2 likes If your question has a deadline — a parcel in transit, a delivery you have to accept or refuse — say so. People answer differently when there is a clock on it.
-
Substitution between formats during a shortage Replied, post #56 · Access › Shortages · 13 Sep 2025 · 21 likes This follows post #55 rather than contradicting it. Where the substitution between formats reasoning breaks down for me is the step from the group result to the…
-
Follow-up: Sodium, potassium and magnesium when intake drops Replied, post #3 · Nutrition & Training › Hydration & electrolytes · 28 Aug 2025 · 0 likes Confirming the opening post from a second method, which matters more than confirming it from a second person. Magnesium: deficiency during weight loss is common and…
-
Are there stupid questions here? A staff answer, at length Replied, post #106 · Start Here › Welcome · 24 Aug 2025 · 2 likes The compound and evidence pages are updated regularly and they are worth reading when you are new. They answer the meta questions like "do we have data on this" and…
-
Persistent vomiting and the threshold for seeking help Replied, post #11 · Safety › Adverse events · 28 Jul 2025 · 0 likes The most useful contribution to this subcategory is a completed account: what happened, what was done, and what the outcome was. The right answer here may simply be…
-
High-resolution MS on aggregates and what it can see Replied, post #23 · Analytics › Mass spectrometry · 15 Jul 2025 · 0 likes Building on post #22 rather than restating it. The question underneath high-resolution is usually "how would I tell?" rather than "what is true?", and that one has a…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #38 · Analytics › Home & field testing · 14 Jul 2025 · 5 likes Ultraviolet absorbance at 280 nanometres estimates concentration for peptides containing aromatic residues and gives nothing for peptides that do not. Knowing which…
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #27 · Devices › Syringes & needles · 11 Jun 2025 · 7 likes Needle length for subcutaneous delivery is a question about tissue depth and injection angle together. Short needles at ninety degrees and longer ones at an angle reach…
-
Holding a dose indefinitely: is there a documented downside? Replied, post #25 · Practice › Dosing & titration · 10 Jun 2025 · 6 likes The bit of holding a dose that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread will…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #101 · Compounds › Cagrilintide & amylin analogues · 3 Apr 2025 · 0 likes On cagrilintide alone: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #90 · Compounds › Cagrilintide & amylin analogues · 2 Apr 2025 · 0 likes Combination products complicate the certificate question considerably. Two active components mean two purity determinations and a ratio, and a single figure for a…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #90 · Compounds › Cagrilintide & amylin analogues · 31 Mar 2025 · 4 likes What is genuinely unknown about long-term amylin agonism: real-world response rates, whether effect is durable with continued use, whether satiety adaptation occurs…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #21 · Wellbeing › Mental health · 20 Mar 2025 · 0 likes The arithmetic in post #19 is right; the assumption feeding it is the part to check. Mood and anxiety: mood changes and anxiety are reported by some people. Baseline…
-
How compounding permissions changed when supply normalised Replied, post #29 · Sourcing › Regulatory · 11 Mar 2025 · 2 likes Thank you for the correction. I would rather find out here than later.
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #29 · Compounds › Semaglutide · 5 Mar 2025 · 6 likes Adding the measurement that post #28 says would settle it. The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30,…
-
What a seizure notice actually says Replied, post #38 · Sourcing › Logistics · 1 Mar 2025 · 5 likes Post #34 and I disagree about the size of the effect, not about the direction. On seizure notice, the part that usually goes wrong is that the question is asked as…
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #40 · Evidence › Journal club · 28 Feb 2025 · 0 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
-
Preservatives: function, testing, and limits Replied, post #14 · Pharmacology › Formulation chemistry · 25 Feb 2025 · 15 likes The question underneath preservatives is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what you would…
-
Canadian access and provincial variation Replied, post #52 · Regional › North America · 4 Feb 2025 · 32 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
SNAC and the mechanism of oral peptide absorption — the long version Replied, post #21 · Compounds › Oral incretins · 6 Jan 2025 · 9 likes Everything in post #17 holds. The case it does not cover is the one I have. Oral bioavailability is variable between people. Some people absorb well; others absorb…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #38 · Evidence › Journal club · 4 Jan 2025 · 0 likes On post #34 — agreed on the reasoning, with one qualification. An update on my earlier SURMOUNT-1 post: the pattern held for another six weeks and then stopped, which I…
-
Scheduled maintenance and what will be unavailable Replied, post #5 · Meta › Announcements · 31 Dec 2024 · 13 likes The rare case here is the one that costs somebody a week, though, and the common case costs everyone ten seconds. I think the trade is clearly correct.
-
Oxidation pathways for methionine and tryptophan Replied, post #59 · Analytics › Impurities & related substances · 31 Dec 2024 · 16 likes On post #57 — agreed on the reasoning, with one qualification. Worth separating oxidation pathways for methionine as a question about the compound from oxidation…
-
Athletes in weight-category sports: a different risk calculus — a second dataset Replied, post #41 · Clinical › Special populations · 9 Dec 2024 · 0 likes Athletes in weight-category sports is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly.…
-
Coming back to: When to suspect the method rather than the sample Replied, post #43 · Analytics › Method validation · 8 Dec 2024 · 19 likes Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance.
-
Follow-up: Recovery when intake is low: what to cut first Replied, post #19 · Nutrition & Training › Resistance training · 12 Nov 2024 · 1 like Recovery sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #132 · Clinical › Bloodwork · 22 Oct 2024 · 10 likes Adding a data point of agreement rather than a data point.
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #24 · Clinical › Comorbidities · 12 Oct 2024 · 2 likes Nothing to add, except that this is the answer I would give if asked.
-
Requesting a page: what makes a good request — what changed since Replied, post #38 · Documentation › Wiki requests · 10 Oct 2024 · 26 likes Scope creep: if you think a page is attempting too much and should be split into multiple pages, that is a reasonable suggestion. Small point, but it is the one that…
-
Correlation in a self-tracked dataset: what it can support Replied, post #47 · Research Methods › Statistics · 22 Aug 2024 · 4 likes Post #45 and I disagree about the size of the effect, not about the direction. I think the correlation question is answerable and has not been answered, which is a more…